A global approach to AGP use – To ban or not to ban?

No one would dispute that safeguarding the benefits of antibiotics for treatment of human diseases is paramount. But is banning on their use as growth promoters a wise move? What can Europe expect now? And what can we do to smooth the transition? Sarah Mellor joined some of the world’s experts in the Netherlands to find out… This article can also be found at Feed Mix, volume 13, no. 2   Join 26,000+ subscribers Subscribe to our newsletter to stay updated about